|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-6-18
|
|
pubmed:abstractText |
The Vienna Challenge Chamber (VCC) offers a controlled and controllable paradigm in which to reproducibly evaluate the efficacy of anti-allergic treatment. The aim of this study was to assess the efficacy of the novel intranasal corticosteroid fluticasone furoate (FF) in the VCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1833-40
|
|
pubmed:meshHeading |
pubmed-meshheading:18498678-Adolescent,
pubmed-meshheading:18498678-Adult,
pubmed-meshheading:18498678-Androstadienes,
pubmed-meshheading:18498678-Cross-Over Studies,
pubmed-meshheading:18498678-Double-Blind Method,
pubmed-meshheading:18498678-Environmental Exposure,
pubmed-meshheading:18498678-Glucocorticoids,
pubmed-meshheading:18498678-Humans,
pubmed-meshheading:18498678-Male,
pubmed-meshheading:18498678-Middle Aged,
pubmed-meshheading:18498678-Poaceae,
pubmed-meshheading:18498678-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:18498678-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
|
|
pubmed:affiliation |
ENT University Clinic, Vienna, Austria. petra@zieglmayer.at
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
